BCL2/IGH t (14;18) gene fusion probe, IGH/BCL2 (CE-IVD)
Catalog No : FP-040
513.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | BCL2/IGH t (14;18) gene fusion probe, IGH/BCL2 (CE-IVD) | ||
|---|---|---|---|
| Catalog No | FP-040 | ||
| Supplier’s Catalog No | FP-040 | ||
| Supplier | Wuhan Healthcare Biotech | ||
| Source antigen | BCL2/IGH | ||
| Reactivity | BCL2/IGH | ||
| Cross reactivity | None | ||
| Applications | Fluorescence In Situ Hybridization (FISH) | ||
| Molecular weight | N/A | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Molecular diagnostic grade | ||
| Purity | N/A | ||
| Form | Liquid | ||
| Reactivity life | 12 months when stored properly according to instructions | ||
| Note | For Professional In Vitro diagnostics | ||
| Description | The t(14;18) translocation occurred in 85% of follicular lymphoma (FL) and 1/3 of diffuse lymphoma (DL) with a poor prognosis. Studies have shown that BCL2/IGH translocation rearrangement plays a role in stimulating B lymphocyte hyperproliferation. The incidence of most translocations in patients with non-Hodgkin's lymphoma is significantly higher than that in healthy controls. | ||
Product Details
© 2020 Imugex All Rights Reserved